<code id='010B179053'></code><style id='010B179053'></style>
    • <acronym id='010B179053'></acronym>
      <center id='010B179053'><center id='010B179053'><tfoot id='010B179053'></tfoot></center><abbr id='010B179053'><dir id='010B179053'><tfoot id='010B179053'></tfoot><noframes id='010B179053'>

    • <optgroup id='010B179053'><strike id='010B179053'><sup id='010B179053'></sup></strike><code id='010B179053'></code></optgroup>
        1. <b id='010B179053'><label id='010B179053'><select id='010B179053'><dt id='010B179053'><span id='010B179053'></span></dt></select></label></b><u id='010B179053'></u>
          <i id='010B179053'><strike id='010B179053'><tt id='010B179053'><pre id='010B179053'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:676
          Adobe

          It is one of health care’s most vexing quandaries: Patient data must be shared to develop more effective medicines and artificial intelligence tools, but there’s no way to share it without violating privacy and basic data rights.

          Or is there?

          advertisement

          A fresh crop of companies is building a new data economy that enables the shared use of personal health information while enforcing ironclad privacy protections. They are not a monolithic group: each one uses its own methods and technologies, serves different customers, and is motivated by distinct problems and personal philosophies.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Merck to buy EyeBio, maker of eye drug, as it grows pipeline
          Merck to buy EyeBio, maker of eye drug, as it grows pipeline

          AdobeLONDON—MercksaidWednesdayitisbuyingophthalmology-focusedstartupEyeBioinadealworthupto$3billion,

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          Air quality improving but still lags in Black, Hispanic communities

          High-risebuildingsindowntownLosAngelesseenonahazymorning.FREDERICJ.BROWN/AFPviaGettyImagesTheU.S.ism